The Hayward multiproduct facility houses 1,000L and 2,000L bioreactors
- Mammalian Cell Culture Processes (CHO, NS0, Hybridoma, etc.)
- Inoculum from cell bank to roller bottles
- Seed train single use bioreactors to 250L
- Harvest by depth filtration
Downstream process capabilities focused on Clinical manufacturing
- Single use chromatography and ultrafiltration/diafiltration systems
- Viral inactivation and viral reduction
- Buffer production and product collection in single use technologies.
- Aseptic bulk drug substance filling into bags and bottles for frozen and refrigerated storage
A fully single use facility focus is on technology transfer of new products
- Raw material, in-process, release testing qualification and execution
- 250L Pilot USP and DSP batch capabilities aligned with large - GMP processing
- Stability testing program with analytical support
We operate global quality management systems which comply with national and international standards and regulation.
Sustainability